I-BUY: Director, $181K, 10K shares @ $18.08
SEC Filed: Friday, March 4, 2005 @ 16:05 (4:05PM EDT)
BI-BUY: Biotech Insider Buy
Telik, Inc. is a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat serious diseases. The Company discovered all of its product candidates using its proprietary technology, Target-Related Affinity Profiling (TRAP). The technology exploits a fundamental property of all drugs, which is their selective interactions with proteins. By developing a profile of how small molecule chemicals interact with a reference panel of proteins, the Company may identify compounds active against disease-related protein targets much faster than by alternative technologies. The Company concentrates its efforts on three therapeutic areas: cancer, diabetes and inflammatory diseases.